192 related articles for article (PubMed ID: 33272904)
1. Growth hormone deficiency in adults with Cushing's disease.
Tritos NA
Best Pract Res Clin Endocrinol Metab; 2021 Mar; 35(2):101474. PubMed ID: 33272904
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing's disease.
Boguszewski CL
Pituitary; 2022 Oct; 25(5):760-763. PubMed ID: 35552989
[TBL] [Abstract][Full Text] [Related]
3. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
[No Abstract] [Full Text] [Related]
4. Current concepts of the diagnosis of adult growth hormone deficiency.
Tritos NA; Biller BMK
Rev Endocr Metab Disord; 2021 Mar; 22(1):109-116. PubMed ID: 32959175
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease.
Höybye C; Ragnarsson O; Jönsson PJ; Koltowska-Häggström M; Trainer P; Feldt-Rasmussen U; Biller BM
Eur J Endocrinol; 2010 Apr; 162(4):677-84. PubMed ID: 20089548
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone status following treatment for Cushing's syndrome.
Hughes NR; Lissett CA; Shalet SM
Clin Endocrinol (Oxf); 1999 Jul; 51(1):61-6. PubMed ID: 10468966
[TBL] [Abstract][Full Text] [Related]
7. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.
Feldt-Rasmussen U; Abs R; Bengtsson BA; Bennmarker H; Bramnert M; Hernberg-Ståhl E; Monson JP; Westberg B; Wilton P; Wüster C;
Eur J Endocrinol; 2002 Jan; 146(1):67-74. PubMed ID: 11751070
[TBL] [Abstract][Full Text] [Related]
9. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
10. Impact of Long-Term Growth Hormone Replacement Therapy on Metabolic and Cardiovascular Parameters in Adult Growth Hormone Deficiency: Comparison Between Adult and Elderly Patients.
Scarano E; Riccio E; Somma T; Arianna R; Romano F; Di Benedetto E; de Alteriis G; Colao A; Di Somma C
Front Endocrinol (Lausanne); 2021; 12():635983. PubMed ID: 33716985
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of children treated for Cushing's disease: a single center experience.
Yordanova G; Martin L; Afshar F; Sabin I; Alusi G; Plowman NP; Riddoch F; Evanson J; Matson M; Grossman AB; Akker SA; Monson JP; Drake WM; Savage MO; Storr HL
Pituitary; 2016 Dec; 19(6):612-624. PubMed ID: 27678103
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease and adult growth hormone deficiency: An under-recognized association?
Takahashi Y
Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101816. PubMed ID: 37643935
[TBL] [Abstract][Full Text] [Related]
13. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
Johannsson G; Sunnerhagen KS; Svensson J
Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
[TBL] [Abstract][Full Text] [Related]
14. Influences on quality of life in GH deficient adults and their effect on response to treatment.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
[TBL] [Abstract][Full Text] [Related]
15. The influence of growth hormone on pediatric body composition: A systematic review.
Ferruzzi A; Vrech M; Pietrobelli A; Cavarzere P; Zerman N; Guzzo A; Flodmark CE; Piacentini G; Antoniazzi F
Front Endocrinol (Lausanne); 2023; 14():1093691. PubMed ID: 36843617
[TBL] [Abstract][Full Text] [Related]
16. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
Pecori Giraldi F; Andrioli M; De Marinis L; Bianchi A; Giampietro A; De Martin M; Sacco E; Scacchi M; Pontecorvi A; Cavagnini F
Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
Colson A; Brooke AM; Walker D; Besser GM; Chew SL; Grossman AB; Jenkins PJ; Drake WM; Monson JP
Horm Res; 2006; 66(6):257-67. PubMed ID: 16914933
[TBL] [Abstract][Full Text] [Related]
18. Elevated insulin-like growth factor-1 in Cushing's disease.
English K; Chikani V; Dimeski G; Inder WJ
Clin Endocrinol (Oxf); 2019 Jul; 91(1):141-147. PubMed ID: 30901100
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
